NASDAQ · ORIC
ORIC Pharmaceuticals, Inc.
Healthcare · Biotechnology
$13.72
Down-$0.03 (-0.22%)
Updated Aug 14, 2026, 11:20 AM
SID Score
5.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 944.68M
- P/E ratio
- -7.1
- Dividend yield
- 0.00%
- 52-week range
- $7.23 – $14.93
- Volume
- 1.05M
- Avg. volume
- 1.39M
Price performance
ORIC price history
1M range · 21 trading sessions · Daily adjusted prices
ORIC closed at $13.72 after 21 trading sessions, up 27.87% for the selected period.
- Last close
- $13.72
- Period change
- +27.87%
- Period low
- $10.42
- Period high
- $13.75
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 13, 2026 | $13.89 | $14.00 | $13.425 | $13.72 | 1.05M |
| Aug 12, 2026 | $13.72 | $13.985 | $13.45 | $13.75 | 1.15M |
| Aug 11, 2026 | $13.64 | $14.1182 | $13.54 | $13.73 | 1.02M |
| Aug 10, 2026 | $13.49 | $13.80 | $13.115 | $13.62 | 1.31M |
| Aug 7, 2026 | $12.95 | $13.50 | $12.78 | $13.50 | 1.33M |
| Aug 6, 2026 | $13.005 | $13.19 | $12.735 | $12.93 | 887.67K |
| Aug 5, 2026 | $13.635 | $14.05 | $12.75 | $12.93 | 2.14M |
| Aug 4, 2026 | $10.64 | $13.73 | $10.64 | $13.47 | 5.04M |
| Aug 3, 2026 | $11.33 | $11.445 | $10.45 | $10.60 | 2.46M |
| Jul 31, 2026 | $11.67 | $11.745 | $10.98 | $11.07 | 1.24M |
| Jul 30, 2026 | $11.18 | $11.88 | $11.03 | $11.64 | 1.87M |
| Jul 29, 2026 | $11.89 | $12.00 | $11.01 | $11.28 | 1.87M |
| Jul 28, 2026 | $11.93 | $12.1287 | $11.58 | $11.91 | 1.14M |
| Jul 27, 2026 | $12.11 | $12.57 | $11.92 | $12.02 | 1.71M |
| Jul 24, 2026 | $10.94 | $12.55 | $10.7436 | $12.10 | 3.61M |
| Jul 23, 2026 | $10.51 | $11.46 | $10.50 | $10.89 | 2.17M |
| Jul 22, 2026 | $10.68 | $10.92 | $10.49 | $10.75 | 1.04M |
| Jul 21, 2026 | $10.37 | $11.04 | $10.37 | $10.83 | 1.31M |
| Jul 20, 2026 | $10.755 | $11.00 | $10.38 | $10.42 | 821.94K |
| Jul 17, 2026 | $10.55 | $11.00 | $10.41 | $10.73 | 1.67M |
| Jul 16, 2026 | $11.20 | $11.22 | $10.44 | $10.73 | 1.26M |
Latest ORIC news
The latest Smart Investors Daily articles mentioning ORIC.

